Skip to main content
Premium Trial:

Request an Annual Quote

Have Actin Polymerization. Will Travel

Premium

It has long been accepted that cells benefit from actin polymerization and actomyosin contractility when they migrate, as they give cells the flexibility they need to travel across cell matrices, says a Johns Hopkins University press release. But Johns Hopkins chemical and biomolecular engineering professor Konstantinos Konstantopoulos and his team have found that conventional wisdom doesn't mean much. In studying the way breast cancer cells migrate to form metastases, the team fashioned a microfluidic-based cell migration chamber with channels of different widths and containing an attractant at one end to induce the cells to travel across, the university says.

The results they got in one circumstance were expected: when the cells traveled across the 50 µm-wide channels, actin was evenly distributed over the surfaces of the cells; and when these cells were treated with drugs that inhibited actin polymerization and actomyosin contractility, the cells went nowhere. But when they looked at the 3 µm-wide channels, the researchers found actin only at the leading and trailing edges of the cells, and when these cells were also treated with drugs that inhibited actin polymerization and actomyosin contractility, they weren't inhibited in the same way as the cells traveling through wider channels, Johns Hopkins says.

"Actin polymerization and actomyosin contractility are critical for 2D cell migration but dispensable for migration through narrow channels," Konstantopoulos says. This kind of research elucidates how cancer cells migrate across heterogeneous environments, the university adds. Konstantopoulos' team is already planning to build another microfluidic device with bifurcated channels, with the aim of learning how cancer cells choose one path over another for migration.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.